Bevacizumab Distribution Into Ascitic Fluid Decreases Serum Drug Exposure: A Case of Metastatic Colon Cancer

No abstract available
Source: Therapeutic Drug Monitoring - Category: Drugs & Pharmacology Tags: Letters to the Editor Source Type: research